Learn more

SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RES INSTITUTE)

Overview
  • Total Patents
    36
  • GoodIP Patent Rank
    43,692
  • Filing trend
    ⇩ 50.0%
About

SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RES INSTITUTE) has a total of 36 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2015. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and Mexico. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are SEATTLE CHILDREN S HOSPITAL DBA SEATTLE CHILDREN S RES INST, CHENGDU HUACHUANG BIOTECHNOLOGY CO LTD and JCR PHARMACEUTICALS CO LTD.

Patent filings per year

Chart showing SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RES INSTITUTE)s patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Jensen Michael C 22
#2 Michael C Jensen 5
#3 Scharenberg Andrew M 4
#4 Johnson Adam 4
#5 Crane Courtney 3
#6 Lu Yingjuan J 2
#7 Matthaei James F 2
#8 Jacoby Kyle 2
#9 Pun Suzie 2
#10 Gustafson Joshua 2

Latest patents

Publication Filing date Title
WO2020163634A1 Chimeric cytokine receptors
WO2020160217A1 Microenvironment sensors to regulate engineered gene expression
AU2019217363A1 Closed-system manufacturing process for CAR-T cells
AU2019209432A1 Methods of use for CAR T cells
WO2017044487A1 Genetic engineering of macrophages for immunotherapy
US2016312210A1 Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
CA2963840A1 Long poly(a) plasmids and methods for introduction of long poly(a) sequences into the plasmid
CA2945302A1 Defined composition gene modified t-cell products
US2017029531A1 Inhibition of lactate dehydrogenase 5 (ldh-5) binding, incorporation, internalization and/or endocytosis to immune cells